表紙:てんかんモニタリングデバイスの世界市場(2022年~2029年)
市場調査レポート
商品コード
1063086

てんかんモニタリングデバイスの世界市場(2022年~2029年)

Global Epilepsy Monitoring Devices Market - 2022-2029

出版日: | 発行: DataM Intelligence | ページ情報: 英文 160 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
てんかんモニタリングデバイスの世界市場(2022年~2029年)
出版日: 2022年02月18日
発行: DataM Intelligence
ページ情報: 英文 160 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界のてんかんモニタリングデバイス市場について調査分析し、市場力学、業界分析、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 世界のてんかんモニタリングデバイス市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界のてんかんモニタリングデバイス市場-市場の定義と概要

第3章 世界のてんかんモニタリングデバイス市場-エグゼクティブサマリー

  • 市場の内訳:製品別
  • 市場の内訳:エンドユーザー別
  • 市場の内訳:地域別

第4章 世界のてんかんモニタリングデバイス市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界のてんかんモニタリングデバイス市場-業界分析

  • ポーターのファイブフォース分析
  • 疫学分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 世界のてんかんモニタリングデバイス市場-COVID-19分析

  • 市場のCOVID-19分析
    • COVID-19以前の市場シナリオ
    • 現在のCOVID-19の市場シナリオ
    • COVID-19以後の市場シナリオ/将来の市場シナリオ
  • COVID-19における価格の力学
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界のてんかんモニタリングデバイス市場:製品別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):製品別
    • 市場魅力指数:製品別
  • ウェアラブルデバイス*
    • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2020年~2029年)
  • EEG
  • EMG
  • MEG
  • 脳深部刺激装置
  • その他

第8章 世界のてんかんモニタリングデバイス市場:エンドユーザー別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%):エンドユーザー別
    • 市場魅力指数:エンドユーザー別
  • 病院
    • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2020年~2029年)
  • 外来外科センター(ASC)
  • 在宅医療
  • その他

第9章 世界のてんかんモニタリングデバイス市場:地域別

  • イントロダクション
    • 市場規模分析、100万米ドル(2020年~2029年)、および前年比成長分析(%)(2020年~2029年):地域別
    • 市場魅力指数:地域別
  • 北米
  • 欧州
  • 南米
  • アジア太平洋
  • 中東とアフリカ

第10章 世界のてんかんモニタリングデバイス市場-競合情勢

  • 主な開発と戦略
  • 企業シェア分析
  • 製品のベンチマーク

第11章 世界のてんかんモニタリングデバイス市場の企業プロファイル

  • Empatica Inc.*
    • 企業概要
    • 製品ポートフォリオおよび説明
    • 主要ハイライト
    • 財務概要
  • Compumedics Limited
  • Masimo Corporation
  • PulseGuard International Ltd
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Possum Ltd.

第12章 世界のてんかんモニタリングデバイス市場-DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMMD4723

Market Overview

The global epilepsy monitoring devices market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Epilepsy is a central nervous system (neurological) disorder characterized by abnormal brain activity, resulting in seizures or periods of unusual behaviour, sensations, and, in some cases, loss of awareness.

Market Dynamics

The factors expected to drive the global epilepsy monitoring devices market are the increasing technological developments in disease monitoring devices and the increasing prevalence of epilepsy.

The increasing technological developments in disease monitoring devices is expected to drive the market growth in the forecast period

Despite technological advances in devices that monitor the human body, a patient's seizure diary, as it is commonly referred to, remains the only way to record and count epileptic seizures outside of the clinic.

Even accurate seizure recognition is difficult because approximately half of all seizures are unknown to the patient. A new generation of long-term brain monitoring technologies that continuously record brain activity in the clinic or at home is emerging. It has the potential to improve disease management for epilepsy patients significantly. The evolution of engineering technology in the context of epilepsy offers renewed hope for identifying periods when the likelihood of seizure onset is increased and delivering responsive therapy to prevent epileptic events from occurring. For instance, a number of wearable devices that may be capable of detecting seizures, recording seizure data, and alerting caregivers have emerged. Non-invasive wearable sensors that measure accelerometry, photoplethysmography (PPG), electrodermal activity (EDA), electromyography (EMG), and other signals outside of the traditional clinical setting may be able to detect seizure-related changes. Furthermore, user acceptability of such devices must be a top priority to ensure long-term device use.

Limitations of epilepsy monitoring devices are expected to hamper the market growth

Seizure alert devices may be inconvenient for people who live alone or do not want others to check on them. Devices that detect shaking movements usually do not detect focal impaired awareness (previously known as complex partial) seizures. The majority of currently available devices have not been approved by the United States Food and Drug Administration (FDA). The evidence that these devices work to detect seizures is frequently derived from studies conducted in hospital epilepsy monitoring units and, in some cases, at home. The devices do not notify caregivers of any breathing problems or changes in heart rate, which could be critical in SUDEP (Sudden Unexpected Death in Epilepsy). Furthermore, the low specificity of changes in heart rate, low electrode stability, and discomfort with long-term use are some disadvantages of EKG as a seizure detection signal.

COVID-19 Impact Analysis

Epilepsy, which affects approximately 50 million people worldwide, is one of the most common neurological diseases and a major cause of disability and mortality, affecting the quality of life and social aspects such as driving or work and necessitating long-term management. Despite the fact that current antiseizure medications effectively control seizures in most patients, one-third of them continue to have seizures (drug-resistant epilepsy). Regular outpatient consultations are thus essential for optimizing antiseizure therapy, managing epilepsy-related behavioural or psychological problems, treating concomitant neurological disorders, conveying psychological support, counselling on family planning, and releasing certifications for a driver's license or fitness work. All of these activities were hampered by the containment measures to deal with the pandemic. The reorganization of healthcare systems inevitably prioritized the management of patients with COVID-19 infection, limiting hospital access for patients with other chronic disorders (including those with epilepsy), and postponing, rescheduling, or even cancelling appointments and examinations.

Furthermore, the industrial lockdown resulted in the halt of management of patients with seizures. Smartphone apps greatly improved communication and information sharing between patients, their families, and caring physicians. Hence, the switch to technology-based management of diseases is expected to drive the demand for seizure monitoring devices due to the covid-19 impact in the forecast period.

Segment Analysis

The wearable devices segment is expected to dominate the market growth

Wearable sensing devices are gaining popularity in general and medical applications such as seizure detection. Wearable devices may also allow for more accurate forecasts of seizure likelihood, allowing people with epilepsy to take quick-acting medications or modify their activities in anticipation of an impending seizure. Currently, two FDA and EU-approved wearable sensors detect convulsive seizures. The first, and accelerometry and EDA wrist-worn smartwatch (Empatica Embrace, Boston MA), detects the subject's movements and maintains a Bluetooth link to the subject's smartphone, where an application transmits data and detections to cloud servers and issues caregiver alerts for seizures.

Wearable diagnostic devices have several advantages. The wearable detectors do not take long to set up and do not limit the user's mobility. They have the ability to track information outside of a hospital setting. Wearable seizure detectors are popular among patients and their families because they can improve patient safety, prevent injuries, and increase independence. Approximately 40% of patients are unaware of their seizures, and he added that wearable devices could help these patients identify problems. Furthermore, the devices could detect nocturnal seizures that would otherwise go unnoticed. Hence, the advanatges wearable devices provide is expected to drive this segment's market growth.

Geographical Analysis

North America region is expected to hold the largest market share in the global epilepsy monitoring devices market

The rising prevalence of epilepsy in this region and major key players are expected to boost the market growth.

It is estimated that approximately 1.2 percent of people in the United States have active epilepsy. This equates to approximately 3.4 million people in the United States and more than 65 million worldwide. Furthermore, approximately 1 in every 26 people will develop epilepsy at some point in their lives.

Furthermore, a U.S based company Empatica Inc., develops medical-grade wearables, software, and algorithms for physiological data collection and interpretation. On February 6th, 2018, received the FDA approval for Embrace, a seizure-alerting smartwatch that detects generalized tonic-clonic seizures and sends alerts to caregivers. It also keeps track of the patient's activity, stress levels, and overall balance. Hence, increasing FDA approvals and the presence of key players in this region are expected to drive market growth.

Competitive Landscape

The global epilepsy monitoring devices market is moderately competitive with mergers, acquisitions, and product launches. Some of the key players in the market are Compumedics Limited, Empatica, Inc., Masimo Corporation, PulseGuard International Ltd., Koninklijke Philips N.V., Medtronic plc, Natus Medical Incorporated, Nihon Kohden Corporation, Possum Ltd.

Empatica Inc.

Overview: Empatica Inc. is a Cambridge, MA-based MIT Media Lab spinoff company that provides AI-enabled tools to advance forecasting, monitoring, research, and treatment. Empatica develops medical-grade wearables, software, and algorithms for physiological data collection and interpretation. The company was founded in 2013.

Product Portfolio: Embrace2 is the world's only FDA-approved wrist-worn epilepsy wearable. It constantly monitors physiological signals and immediately alerts family, friends, and caregivers in the event of a seizure.

Key Developments: On January 11th, 2019, The FDA approved Empatica's seizure-sensing Embrace wristband for children aged six to twenty-one. The device detects tonic-clonic seizures and alerts caregivers, increasing the likelihood that someone will assist the patient in the critical moments following an event.

Why Purchase the Report?

  • Visualize the composition of the global epilepsy monitoring devices market segmentation by product and end user, highlighting the key commercial assets and players.
  • Identify commercial opportunities in the global epilepsy monitoring devices market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of global epilepsy monitoring devices market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global epilepsy monitoring devices market report would provide an access to an approx. 45+market data table, 40+ figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Market Segmentation

Global Epilepsy Monitoring Devices Market- By Product

  • Wearable Devices
  • EEG
  • EMG
  • MEG
  • Deep Brain Stimulation Devices
  • Others

Global Epilepsy Monitoring Devices Market- By End User

  • Hospitals
  • Ambulatory Surgical Center
  • Home Care Settings
  • Others

Global Epilepsy Monitoring Devices Market- By Region

  • North America
  • Europe
  • South America
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Global Epilepsy Monitoring Devices Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Epilepsy Monitoring Devices Market- Market Definition and Overview

3. Global Epilepsy Monitoring Devices Market- Executive Summary

  • 3.1. Market Snippet By Product
  • 3.2. Market Snippet By End User
  • 3.3. Market Snippet By Region

4. Global Epilepsy Monitoring Devices Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. The increasing technological developments in disease monitoring devices
    • 4.1.2. Restraints:
      • 4.1.2.1. Limitations of epilepsy monitoring devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Epilepsy Monitoring Devices Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Epidemiology Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Epilepsy Monitoring Devices Market- COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Epilepsy Monitoring Devices Market- By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Wearable Devices*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029and Y-o-Y Growth Analysis (%), 2020-2029
  • 7.3. EEG
  • 7.4. EMG
  • 7.5. MEG
  • 7.6. Deep Brain Stimulation Devices
  • 7.7. Others

8. Global Epilepsy Monitoring Devices Market- By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029and Y-o-Y Growth Analysis (%), 2020-2029
  • 8.3. Ambulatory Surgical Center
  • 8.4. Home Care Settings
  • 8.5. Others

9. Global Epilepsy Monitoring Devices Market- By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029and Y-o-Y Growth Analysis (%), 2020-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

10. Global Epilepsy Monitoring Devices Market- Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking

11. Global Epilepsy Monitoring Devices Market Company Profiles

  • 11.1. Empatica Inc.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Compumedics Limited
  • 11.3. Masimo Corporation
  • 11.4. PulseGuard International Ltd
  • 11.5. Koninklijke Philips N.V.
  • 11.6. Medtronic plc
  • 11.7. Natus Medical Incorporated
  • 11.8. Nihon Kohden Corporation
  • 11.9. Possum Ltd.

LIST NOT EXHAUSTIVE

12. Global Epilepsy Monitoring Devices Market- DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us